Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral hypoglycemic agents versus insulin for gestational diabetes mellitus
ACTRN12612001272886Phase 3Completed
- Sponsor
- Dr Aisha Syed Wali
- Start
- Jan 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of metformin, glibenclamide and human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Dr Aisha Syed Wali. Primary endpoint: Glycemic control based on self-monitored blood glucose. Started Jan 2013; status: completed.
02
Drugs
metforminglibenclamidehuman insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on ACTRN12612001272886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001272886.